LENSAR designs and develops laser systems for cataract treatment and offers solutions aimed at improving outcomes and efficiency in eye surgeries. Self-described as a premier cataract treatment platform.

LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision. The company was incorporated in 2004 and is headquartered in Orlando, Florida.

COM:LENSAR

LENSAR

Last Close

5.68

01/11 20:00

Market Cap

51.86M

Beta: -

Volume Today

22.53K

Avg: -

locale

market

industry

website

ipo date

peer of

competitor of

Metrics